Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
暂无分享,去创建一个
Jie Ding | Hongwen Zhang | X. Zhong | Xiao-yu Liu | Yanling Yang | Fang Wang | Suxia Wang | H. Xiao | Yong Yao
[1] Haiyan Yu,et al. Case Report: A Rare Case of Thrombotic Microangiopathy Induced by Remethylation Disorders , 2022, Frontiers in Medicine.
[2] Zhao Hu,et al. Case Report: Membranous Nephropathy Secondary to Cobalamin C Disease , 2022, Frontiers in Medicine.
[3] C. Dionisi-Vici,et al. Ocular manifestations in patients with inborn errors of intracellular cobalamin metabolism: a systematic review , 2021, Human Genetics.
[4] Xue-ming Zhu,et al. Proteinuria as a presenting sign of combined methylmalonic acidemia and homocysteinemia: case report , 2020, BMC medical genetics.
[5] Dong Li,et al. Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review. , 2019, European journal of medical genetics.
[6] X. Kong,et al. Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria , 2018, BMC Medical Genetics.
[7] D. Cassiman,et al. Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy , 2018, Kidney international reports.
[8] Dexuan Wang,et al. Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia , 2017, Medicine.
[9] Songming Huang,et al. Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report , 2017, Experimental and therapeutic medicine.
[10] F. Kok,et al. Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls , 2017, Pediatric Nephrology.
[11] B. Knebelmann,et al. Case report and literature review , 2016, Medicine.
[12] A. Diepstra,et al. Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity , 2016, Pediatric Nephrology.
[13] W. Zein,et al. Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency. , 2016, Ophthalmology.
[14] A. Losito,et al. Combined Pulmonary Hypertension and Renal Thrombotic Microangiopathy in Cobalamin C Deficiency , 2013, Pediatrics.
[15] S. Testa,et al. Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria , 2012, Pediatric Nephrology.
[16] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[17] Xuefan Gu,et al. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China , 2010, Journal of Inherited Metabolic Disease.
[18] K. Hsiao,et al. Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria , 2010, Journal of Human Genetics.
[19] M. Baumgartner,et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.
[20] Susan L Furth,et al. New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.
[21] G. Uziel,et al. Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.
[22] C. Greenberg,et al. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder , 2007, Pediatric Nephrology.
[23] E. Shoubridge,et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.
[24] D. C. Henckel,et al. Case report. , 1995, Journal.